Caplacizumab Interactions
There are 159 drugs known to interact with caplacizumab, along with 2 disease interactions. Of the total drug interactions, 71 are major, 82 are moderate, and 6 are minor.
- View caplacizumab disease interactions (2)
Medications known to interact with caplacizumab
Note: Showing generic names only.
- abciximab
- abrocitinib
- acalabrutinib
- ado-trastuzumab emtansine
- aducanumab
- alemtuzumab
- alteplase
- anacaulase topical
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- aspirin
- avapritinib
- cabozantinib
- calaspargase pegol
- cangrelor
- capsicum
- celecoxib
- chamomile
- cilostazol
- citalopram
- clomipramine
- clopidogrel
- clove
- collagenase clostridium histolyticum
- dabigatran
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dipyridamole
- donanemab
- dong quai
- drotrecogin alfa
- duloxetine
- edoxaban
- efgartigimod alfa
- enoxaparin
- epoprostenol
- eptifibatide
- escitalopram
- etodolac
- evening primrose
- fedratinib
- fenfluramine
- fenoprofen
- fenugreek
- feverfew
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
- panobinostat
- paroxetine
- pegaspargase
- pentosan polysulfate sodium
- pentoxifylline
- phenylbutazone
- piroxicam
- pirtobrutinib
- plasminogen, human
- ponatinib
- prasugrel
- protein c
- tafasitamab
- tazemetostat
- tenecteplase
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tositumomab
- tovorafenib
- treprostinil
- turmeric
Caplacizumab disease interactions
There are 2 disease interactions with caplacizumab which include:
More about caplacizumab
- caplacizumab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet aggregation inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Adzynma
Adzynma (ADAMTS13, recombinant-krhn) is a human recombinant protein that may be used to prevent or ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Aggrenox
Aggrenox (aspirin and dipyridamole) is used to reduce the risk of stroke in people who have had ...
Arthritis Pain
Arthritis Pain is used for angina, angina pectoris prophylaxis, ankylosing spondylitis ...
Ascriptin
Ascriptin is used for angina, angina pectoris prophylaxis, antiphospholipid syndrome, back pain ...
Aspergum
Aspergum is used for angina, angina pectoris prophylaxis, ankylosing spondylitis, antiphospholipid ...
Aspir-Low
Aspir-Low is used for angina, angina pectoris prophylaxis, heart attack, ischemic stroke, ischemic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.